Neil Abdollahian
2019
In 2019, Neil Abdollahian earned a total compensation of $796.5K as Chief Business Officer at Cidara Therapeutics, a 24% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $185,300 |
|---|---|
| Option Awards | $188,375 |
| Salary | $362,000 |
| Stock Awards | $58,000 |
| Other | $2,800 |
| Total | $796,475 |
Abdollahian received $362K in salary, accounting for 45% of the total pay in 2019.
Abdollahian also received $185.3K in non-equity incentive plan, $188.4K in option awards, $58K in stock awards and $2.8K in other compensation.
Rankings
In 2019, Neil Abdollahian's compensation ranked 10,232nd out of 13,971 executives tracked by ExecPay. In other words, Abdollahian earned more than 26.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,232 out of 13,971 | 27th |
Division Manufacturing | 4,143 out of 5,701 | 27th |
Major group Chemicals And Allied Products | 1,584 out of 2,200 | 28th |
Industry group Drugs | 1,357 out of 1,886 | 28th |
Industry Biological Products, Except Diagnostic Substances | 301 out of 389 | 23rd |
Source: SEC filing on April 29, 2020.
Abdollahian's colleagues
We found two more compensation records of executives who worked with Neil Abdollahian at Cidara Therapeutics in 2019.